Repare Therapeutics (RPTX) is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its…
Cancer research
An Insatiable Disease Cancer is a grim disease, feeding off numerous sources including tobacco, infections, environmental pollution, occupational carcinogens, and radiation, among others. Whether directly or indirectly, everyone has…
For the last eight months, the Covid-19 virus has been the center of attention in the media, the markets, and the medical field. Collectively, countries and government agencies, and…
Medical Marijuana (MJNA.OTC) announced today that their investment company AXIM Biotechnologies (AXIM.OTC) has signed a binding term sheet to acquire oncology research and development company Sapphire Biotech. Sapphire engages…
Amgen (AMGN.Q) signed a lease with BioMed Realty for a new 240,000 square foot Leadership in Energy and Environmental Design (LEED) candidate facility in the Gateway of Pacific campus…
Oracle Health Sciences, the medical sciences wing of Oracle (ORCL.NYSE), is participating in The Opportunity Project (TOP) Technology Spring: Creating the Future of Health. TOP is a 12-week technology…
Varian Medical Systems (VAR.NYSE) announced that the South Florida Proton Therapy Institute (SFPTI) has treated its first patient using the Varian ProBeam Compact single-room proton therapy system. Face it….
We all know someone who’s been touched by cancer. It’s been called the worst scourge of civilized mankind. It sweeps through a family, disrupting our perfectly ordered lives, throwing…
Cannabis research play Veritas Pharmaceuticals (VRT.C) announced news after yesterday’s close, as predicted here at Equity.Guru, and the news was most definitely good. If you’re in the cancer research…